1180 related articles for article (PubMed ID: 33989756)
1. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
2. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
3. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology.
Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE
Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578
[TBL] [Abstract][Full Text] [Related]
4. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
5. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
[TBL] [Abstract][Full Text] [Related]
6. Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases.
Matsubayashi S; Ito S; Araya J; Kuwano K
Front Endocrinol (Lausanne); 2023; 14():1079626. PubMed ID: 37077349
[TBL] [Abstract][Full Text] [Related]
7. The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology.
Li B; Lyu P; Tang J; Li J; Ouchi T; Fan Y; Zhao Z; Li L
J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38306619
[TBL] [Abstract][Full Text] [Related]
8. Emerging use of senolytics and senomorphics against aging and chronic diseases.
Martel J; Ojcius DM; Wu CY; Peng HH; Voisin L; Perfettini JL; Ko YF; Young JD
Med Res Rev; 2020 Nov; 40(6):2114-2131. PubMed ID: 32578904
[TBL] [Abstract][Full Text] [Related]
9. Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing?
Balistreri CR; Madonna R; Ferdinandy P
Curr Res Pharmacol Drug Discov; 2021; 2():100027. PubMed ID: 34909661
[TBL] [Abstract][Full Text] [Related]
10. Senotherapeutics: emerging strategy for healthy aging and age-related disease.
Kim EC; Kim JR
BMB Rep; 2019 Jan; 52(1):47-55. PubMed ID: 30526770
[TBL] [Abstract][Full Text] [Related]
11. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
[TBL] [Abstract][Full Text] [Related]
12. Nutritional senolytics and senomorphics: Implications to immune cells metabolism and aging - from theory to practice.
Luís C; Maduro AT; Pereira P; Mendes JJ; Soares R; Ramalho R
Front Nutr; 2022; 9():958563. PubMed ID: 36159455
[TBL] [Abstract][Full Text] [Related]
13. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
Wong PF; Dharmani M; Ramasamy TS
Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
[TBL] [Abstract][Full Text] [Related]
14. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
15. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
16. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
Rossi M; Abdelmohsen K
Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
[TBL] [Abstract][Full Text] [Related]
17. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
[TBL] [Abstract][Full Text] [Related]
18. Cellular Senescence in Idiopathic Pulmonary Fibrosis.
Kellogg DL; Kellogg DL; Musi N; Nambiar AM
Curr Mol Biol Rep; 2021; 7(3):31-40. PubMed ID: 34401216
[TBL] [Abstract][Full Text] [Related]
19. The costs and benefits of senotherapeutics for human health.
Raffaele M; Vinciguerra M
Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323
[TBL] [Abstract][Full Text] [Related]
20. Obesity, Senescence, and Senolytics.
Chaib S; Tchkonia T; Kirkland JL
Handb Exp Pharmacol; 2022; 274():165-180. PubMed ID: 34697668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
